⌘K
Loading ticker…
As of 2026-08-24, Avita Medical, Inc. Common Stock (RCEL) has a 3-month relative strength percentile of 98 and a leadership percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 83. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.7%, relative volume 0.30×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RCEL is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 80.2% / 122.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
RCEL is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $311K notional. Top 3 carry $446K.
Held by 19 ETFs · $7M across latest filings · largest weight 0.01% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| UWM | 0.00% | $2K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $1K | — |
| HDG | 0.00% | $56 | — |
| RB | 0.00% | $13 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RCEL Jan avg: 15.65% median: 24.99% win: 75% σ: 30.79% n: 4 2022-04-12 → 2026-07-31 | RCEL Feb avg: 16.45% median: 11.12% win: 75% σ: 18.98% n: 4 2022-04-12 → 2026-07-31 | RCEL Mar avg: -11.10% median: -11.07% win: 25% σ: 12.51% n: 4 2022-04-12 → 2026-07-31 | RCEL Apr avg: -5.08% median: 11.09% win: 60% σ: 29.63% n: 5 2022-04-12 → 2026-07-31 | RCEL May avg: -12.07% median: -6.56% win: 40% σ: 22.27% n: 5 2022-04-12 → 2026-07-31 | RCEL Jun avg: 0.84% median: -5.87% win: 20% σ: 27.55% n: 5 2022-04-12 → 2026-07-31 | RCEL Jul avg: 13.61% median: 18.53% win: 100% σ: 9.83% n: 5 2022-04-12 → 2026-07-31 | RCEL Aug avg: -8.09% median: -11.30% win: 25% σ: 13.70% n: 4 2022-04-12 → 2026-07-31 (current) | RCEL Sep avg: 1.80% median: 2.08% win: 50% σ: 16.71% n: 4 2022-04-12 → 2026-07-31 | RCEL Oct avg: -18.38% median: -15.74% win: 0% σ: 14.59% n: 4 2022-04-12 → 2026-07-31 | RCEL Nov avg: 18.26% median: 20.72% win: 75% σ: 17.48% n: 4 2022-04-12 → 2026-07-31 | RCEL Dec avg: 5.26% median: -0.45% win: 25% σ: 15.91% n: 4 2022-04-12 → 2026-07-31 |